Evidence map›Paper›PMID 27080392›Full record

ArticleMolecular brain2016

Lysosomal iron modulates NMDA receptor-mediated excitation via small GTPase, Dexras1.

Rachel S White, Anup K Bhattacharya, Yong Chen, Madeleine Byrd, Mary F McMullen, Steven J Siegel, Gregory C Carlson, Sangwon F Kim

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Molecular brain, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07759895 (Combination Therapy of Deferiprone and N-Acetylcysteine for Treating Negative Symptoms in Schizophrenia), which is not on this map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
4.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07759895 phase2not yet recruitingnot on this mapstarted 2026, after this paper: background citation

Combination Therapy of Deferiprone and N-Acetylcysteine for Treating Negative Symptoms in Schizophrenia

TypeinterventionalSponsorAmit LotanRan2026 to 2029Enrolled80ConditionsSchizoaffecitve Disorder, Schizophrenia and Schizoaffective Disorder, Schizophrenia and Predominant Negative SymptomsArmsDeferiprone (DFP), N-Acetyl Cysteine (NAC)
3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 45 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. The Endolysosomal Transporter DMT1 is Required for Morphine Regulation of Neuronal Ferritin Heavy Chain.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2023
    Article
  8. Article
  9. Genetic Analysis ofBalkan medical journal · 2022
    Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Opioid Modulation of Neuronal Iron and Potential Contributions to NeuroHIV.Methods in molecular biology (Clifton, N.J.) · 2021
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Rachel S WhiteDepartment of Psychiatry, Center for Neurobiology and Behavior, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, 19104, USA.
Anup K BhattacharyaDepartment of Psychiatry, Center for Neurobiology and Behavior, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, 19104, USA.
Yong ChenDepartment of Psychiatry, Center for Neurobiology and Behavior, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, 19104, USA.
Madeleine ByrdDepartment of Psychiatry, Center for Neurobiology and Behavior, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, 19104, USA.
Mary F McMullenDepartment of Psychiatry, Center for Neurobiology and Behavior, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, 19104, USA.
Steven J SiegelDepartment of Psychiatry, Center for Neurobiology and Behavior, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, 19104, USA.
Gregory C CarlsonDepartment of Psychiatry, Center for Neurobiology and Behavior, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, 19104, USA.
Sangwon F KimDepartment of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine at the University of Pennsylvania, 125 S 31st, TRL RM 2207, Philadelphia, PA, 19104, USA. sangwonk@mail.med.upenn.edu.
University of Pennsylvania · USTranslational Therapeutics (United States) · US

Funding

TRANSGENIC MOUSE MODELS OF MENTAL RETARDATIONP30HD026979 · NICHD · CHILDREN'S HOSP OF PHILADELPHIA · PI ROBINSON, MICHAEL BYRNE · 1990 to 2015
$15.3M
The Intellectual and Developmental Disabilities Research Center at CHOP/PennU54HD086984 · NICHD · CHILDREN'S HOSP OF PHILADELPHIA · PI SCHULTZ, ROBERT THOMAS · 2016 to 2020
$6.3M
Molecular basis of atypical antipsychotic drugs-induced weight gainR01DK084336 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI KIM, SANGWON F · 2010 to 2014
$1.5M
Dextras1, Brain Iron Homeostasis and Mental HealthR00MH079614 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI KIM, SANGWON F · 2008 to 2010
$793k
Dexras1, Brain Iron Homeostasis and Mental HealthK99MH079614 · NIMH · JOHNS HOPKINS UNIVERSITY · PI KIM, SANGWON F · 2007 to 2008
$96k
NICHD NIH HHS HD026979NICHD NIH HHS P30 HD026979NICHD NIH HHS U54 HD086984NIDDK NIH HHS DK084336NIDDK NIH HHS R01 DK084336NIMH NIH HHS K99 MH079614NIMH NIH HHS MH079614NIMH NIH HHS R00 MH079614
6 · The paper itself

Abstract

backgroundActivation of NMDA receptors can induce iron movement into neurons by the small GTPase Dexras1 via the divalent metal transporter 1 (DMT1). This pathway under pathological conditions such as NMDA excitotoxicity contributes to metal-catalyzed reactive oxygen species (ROS) generation and neuronal cell death, and yet its physiological role is not well understood.

resultsWe found that genetic and pharmacological ablation of this neuronal iron pathway in the mice increased glutamatergic transmission. Voltage sensitive dye imaging of hippocampal slices and whole-cell patch clamping of synaptic currents, indicated that the increase in excitability was due to synaptic modification of NMDA receptor activity via modulation of the PKC/Src/NR2A pathway. Moreover, we identified that lysosomal iron serves as a main source for intracellular iron signaling modulating glutamatergic excitability.

conclusionsOur data indicates that intracellular iron is dynamically regulated in the neurons and robustly modulate synaptic excitability under physiological condition. Since NMDA receptors play a central role in synaptic neurophysiology, plasticity, neuronal homeostasis, neurodevelopment as well as in the neurobiology of many diseases, endogenous iron is therefore likely to have functional relevance to each of these areas.

Indexed as

AnimalsCytosolExcitatory Postsynaptic PotentialsHydrazinesIntracellular MembranesIronIron Chelating AgentsLysosomesMice, Inbred C57BLModels, BiologicalPhosphorylationPyramidal Cellsras ProteinsReceptors, AMPAReceptors, N-Methyl-D-AspartateSignal TransductionhydrazineHydrazinesIronIron Chelating AgentsRasd1 protein, mouseras ProteinsReceptors, AMPAReceptors, N-Methyl-D-Aspartatesrc-Family Kinases

Identifiers

PMID27080392
PMCPMC4832449
OpenAlexW2337215808

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.